Xinjiang Bai Hua Cun Pharma Tech Co Ltd banner

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721

Watchlist Manager
Xinjiang Bai Hua Cun Pharma Tech Co Ltd Logo
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Watchlist
Price: 9.1 CNY -0.98% Market Closed
Market Cap: ¥3.5B

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Total Receivables

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Total Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Receivables CAGR 3Y CAGR 5Y CAGR 10Y
Xinjiang Bai Hua Cun Pharma Tech Co Ltd
SSE:600721
Total Receivables
¥228.6m
CAGR 3-Years
3%
CAGR 5-Years
0%
CAGR 10-Years
2%
I
Inner Mongolia BaoTou Steel Union Co Ltd
SSE:600010
Total Receivables
¥14.9B
CAGR 3-Years
13%
CAGR 5-Years
8%
CAGR 10-Years
4%
Baoshan Iron & Steel Co Ltd
SSE:600019
Total Receivables
¥37.8B
CAGR 3-Years
-3%
CAGR 5-Years
-4%
CAGR 10-Years
7%
W
Western Superconducting Technologies Co Ltd
SSE:688122
Total Receivables
¥5B
CAGR 3-Years
10%
CAGR 5-Years
20%
CAGR 10-Years
N/A
C
CITIC Pacific Special Steel Group Co Ltd
SZSE:000708
Total Receivables
¥20.6B
CAGR 3-Years
8%
CAGR 5-Years
10%
CAGR 10-Years
34%
Inner Mongolia Dazhong Mining Co Ltd
SZSE:001203
Total Receivables
¥349m
CAGR 3-Years
3%
CAGR 5-Years
-10%
CAGR 10-Years
N/A
No Stocks Found

Xinjiang Bai Hua Cun Pharma Tech Co Ltd
Glance View

Market Cap
3.5B CNY
Industry
Metals & Mining

Xinjiang Baihuacun Pharam Tech Co., Ltd. provides medical research and development services as a contract research organization (CRO). The company is headquartered in Urumqi, Xinjiang and currently employs 722 full-time employees. The firm's main business is the research and development, registration and application of small molecule chemicals and the development of peptide drugs. The firm is engaged in the early discovery and screening of new drugs, drug clinical trials, biological sample analysis, medicine testing services, active pharmaceutical ingredient (API) and intermediate supply. The firm is also engaged in leasing and property services. The firm mainly conducts business within the domestic market.

Intrinsic Value
3.34 CNY
Overvaluation 63%
Intrinsic Value
Price ¥9.1

See Also

What is Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Total Receivables?
Total Receivables
228.6m CNY

Based on the financial report for Sep 30, 2025, Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Total Receivables amounts to 228.6m CNY.

What is Xinjiang Bai Hua Cun Pharma Tech Co Ltd's Total Receivables growth rate?
Total Receivables CAGR 10Y
2%

Over the last year, the Total Receivables growth was 0%. The average annual Total Receivables growth rates for Xinjiang Bai Hua Cun Pharma Tech Co Ltd have been 3% over the past three years , and 2% over the past ten years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett